Jushi Holdings Inc. (OTCMKTS:JUSHF - Free Report) - Analysts at Seaport Res Ptn reduced their FY2024 earnings per share (EPS) estimates for Jushi in a research report issued to clients and investors on Monday, November 25th. Seaport Res Ptn analyst S. Randhawa now forecasts that the company will post earnings of ($0.17) per share for the year, down from their previous forecast of ($0.11). The consensus estimate for Jushi's current full-year earnings is ($0.21) per share. Seaport Res Ptn also issued estimates for Jushi's Q4 2024 earnings at ($0.05) EPS, Q1 2025 earnings at ($0.04) EPS, Q2 2025 earnings at ($0.04) EPS and FY2025 earnings at ($0.14) EPS.
Separately, Ventum Cap Mkts raised Jushi to a "hold" rating in a report on Thursday, August 8th.
Check Out Our Latest Analysis on Jushi
Jushi Stock Down 0.7 %
Shares of Jushi stock traded down $0.00 on Wednesday, reaching $0.35. 296,678 shares of the stock were exchanged, compared to its average volume of 263,934. Jushi has a twelve month low of $0.22 and a twelve month high of $1.09. The business has a 50 day moving average price of $0.46 and a two-hundred day moving average price of $0.54. The firm has a market capitalization of $68.29 million, a price-to-earnings ratio of -1.29 and a beta of -0.86.
Jushi (OTCMKTS:JUSHF - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.04). The company had revenue of $61.61 million during the quarter, compared to analysts' expectations of $65.53 million. Jushi had a negative return on equity of 5,529.11% and a negative net margin of 20.93%.
Jushi Company Profile
(
Get Free Report)
Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.
Featured Articles
Before you consider Jushi, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.
While Jushi currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
